Globus Medical (GMED) Tops Q2 EPS by 18c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Northland Capital Markets Upgrades Globus Medical (GMED) to Outperform
August 6, 2020 7:48 AM EDTNorthland Capital Markets analyst Jason Wittes upgraded Globus Medical (NYSE: GMED) from Market Perform to Outperform with a price target of $65.00.
The analyst commented, "2Q revs of $148.9mm (-23.4%) and EPS of $0.07, easily bested consensus of $99.7mm and ($0.11). Not a complete surprise,... More
